128 related articles for article (PubMed ID: 7925212)
1. Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humans.
Wierda JM; Proost JH; Schiere S; Hommes FD
Eur J Anaesthesiol Suppl; 1994; 9():66-74. PubMed ID: 7925212
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of rocuronium at the vocal cords and the adductor pollicis in humans.
Plaud B; Proost JH; Wierda JM; Barre J; Debaene B; Meistelman C
Clin Pharmacol Ther; 1995 Aug; 58(2):185-91. PubMed ID: 7648768
[TBL] [Abstract][Full Text] [Related]
3. Neuromuscular recovery following rocuronium bromide single dose in infants.
Rapp HJ; Altenmueller CA; Waschke C
Paediatr Anaesth; 2004 Apr; 14(4):329-35. PubMed ID: 15078379
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of rocuronium bromide in patients with and without renal failure.
Cooper RA; Mirakhur RK; Wierda JM; Maddineni VR
Eur J Anaesthesiol Suppl; 1995 Sep; 11():43-4. PubMed ID: 8557005
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
Han T; Kim H; Bae J; Kim K; Martyn JA
Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of rocuronium bromide in hepatic cirrhosis.
Hunter JM
Eur J Anaesthesiol Suppl; 1995 Sep; 11():39-41. PubMed ID: 8557004
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the differences in the time to onset of action between rocuronium and vecuronium.
Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Salmerón J
Clin Exp Pharmacol Physiol; 2006; 33(1-2):125-30. PubMed ID: 16445711
[TBL] [Abstract][Full Text] [Related]
8. Rocuronium- and mivacurium-induced neuromuscular block and intubating conditions: a comparison with vecuronium.
van den Broek L; Hommes FD; Nap HJ; Wierda JM
Eur J Anaesthesiol Suppl; 1995 Sep; 11():27-30. PubMed ID: 8557002
[TBL] [Abstract][Full Text] [Related]
9. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
Woloszczuk-Gebicka B; Wyska E; Grabowski T
Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
[TBL] [Abstract][Full Text] [Related]
10. Hypothermic cardiopulmonary bypass influences the concentration-response relationship and the biodisposition of rocuronium.
Smeulers NJ; Wierda JM; van den Broek L; Gallandat Huet RC; Hennis PJ
Eur J Anaesthesiol Suppl; 1995 Sep; 11():91-4. PubMed ID: 8557015
[TBL] [Abstract][Full Text] [Related]
11. Target controlled infusion of rocuronium: selection of a pharmacokinetic model.
Vermeyen KM; Hoffmann VL; Saldien V; Adriaensen HF
Acta Anaesthesiol Belg; 2002; 53(1):17-9. PubMed ID: 11975424
[No Abstract] [Full Text] [Related]
12. Pharmacodynamics and pharmacokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia.
Sparr HJ; Khuenl-Brady KS; Eriksson LI
Eur J Anaesthesiol Suppl; 1994; 9():63-5. PubMed ID: 7925211
[TBL] [Abstract][Full Text] [Related]
13. Dose-response and time-course of effect of rocuronium bromide in paediatric patients.
Meretoja OA; Taivainen T; Erkola O; Rautoma P; Juvakoski M
Eur J Anaesthesiol Suppl; 1995 Sep; 11():19-22. PubMed ID: 8557000
[TBL] [Abstract][Full Text] [Related]
14. Rocuronium--onset times and intubating conditions.
Feldman SA
Eur J Anaesthesiol Suppl; 1994; 9():49-52. PubMed ID: 7925208
[TBL] [Abstract][Full Text] [Related]
15. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
16. Dose-response and time-course of action of rocuronium bromide.
Mirakhur RK
Eur J Anaesthesiol Suppl; 1995 Sep; 11():23-5. PubMed ID: 8557001
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.
Woloszczuk-Gebicka B; Wyska E; Grabowski T; Swierczewska A; Sawicka R
Paediatr Anaesth; 2006 Jul; 16(7):761-8. PubMed ID: 16879519
[TBL] [Abstract][Full Text] [Related]
18. Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term.
Fassbender P; Geldner G; Blobner M; Hofmockel R; Rex C; Gautam S; Malhotra A; Eikermann M
Am J Crit Care; 2009 Sep; 18(5):439-45. PubMed ID: 19723864
[TBL] [Abstract][Full Text] [Related]
19. The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans.
Beaufort AM; Wierda JM; Belopavlovic M; Nederveen PJ; Kleef UW; Agoston S
Eur J Anaesthesiol Suppl; 1995 Sep; 11():95-106. PubMed ID: 8557016
[TBL] [Abstract][Full Text] [Related]
20. Sedation after intubation using etomidate and a long-acting neuromuscular blocker.
Kendrick DB; Monroe KW; Bernard DW; Tofil NM
Pediatr Emerg Care; 2009 Jun; 25(6):393-6. PubMed ID: 19458564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
